Navigation Links
2nd ESMO symposium on soft tissue carcinomas and GIST

Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy.

The 2nd Symposium on Sarcoma and GIST (Gastrointestinal Stromal Tumors) organized by the European Society for Medical Oncology (ESMO), will include sessions on the genetics of sarcomas, on understanding how drug resistance develops and possibilities for new treatment options.

There will be a particular focus on how scientists and clinicians can work together to develop new treatments, including molecular targeted therapies. The theme of the meeting is 'Insights at the crossroads of molecular biology, pathology and clinic.'

"Sarcomas are relatively rare, but they are serving as a model for the way new molecular targeted therapies are being introduced into clinical practice," said co-chair of the event Dr. Paolo G. Casali, Head of the Sarcoma Medical Treatment Unit at the Milan Istituto Nazionale Tumori and Chair of the ESMO Sarcoma Working Group. "This challenges our ability to combine information from as diverse areas as biology, pathology and the clinic to achieve better results for patients."

"The molecular and pathological bases represent extremely valuable diagnostic and prognostic information for the proper treatment of this disease, although the way we can exploit all these data in the clinic is still to be defined properly," said co-chair Dr. Paolo Dei Tos, Director of the Pathology Unit of the Regional Hospital of Treviso, Italy.

Sarcomas are cancers of the connective or supportive tissues, such as muscles, tendons, ligaments, nerves, fat and blood vessels, therefore they can arise everywhere in the body, although they are rare. Sarcomas are also different to the much more frequent carcinomas of the breast, colon, lung, and others.

Around 50 different kinds of soft-tissue sarcomas have been identified, affecting around 4 new patients per 100,000 in the population each year. Gastrointestinal stromal tumors, a specific subtype of sarcoma that affects the wall of the stomach and intestine, affect 1.5 new patients per 100,000 people each year.

Among the top clinical and translational researchers who will speak at the symposium there are L. Baker, R. Benjamin, E. de Alava, P. Hogendoorn, G. Demetri, J. Fletcher, L. Helman, M. Ladanyi, R. Maki.

The highly qualified Symposium Faculty, made up of some of the most eminent experts in the field of sarcoma treatment and research, has also organized a two-day closed meeting before the event to discuss ideas for future research projects.

The ESMO Symposium on Sarcoma and GIST is supported by two pharmaceutical companies -- Novartis Oncology and PharmaMar -- and by Conticanet, a EU-funded project for clinical research on soft tissue sarcomas in Europe, whose coordinator, Dr. Jean-Yves Blay, is one program co-chair. The event has been organized also in cooperation with the Milan Istituto Nazionale Tumori, a referral institute for sarcomas and GIST.

"ESMO is dedicated to educating and supporting oncologists, also when it comes to the treatment of specific disease areas such as sarcoma," said Prof. Rolf A. Stahel, Chair of the ESMO Educational Committee.

In line with its commitment to educate and guarantee the best possible treatment to all cancer patients, later this year ESMO will be hosting an event dedicated to rare tumors in Brussels, 'Rare Tumors in Europe: Challenges and Solutions'.

"Sarcomas being rare cancers make this meeting a significant expression of ESMO's efforts on rare diseases," said Dr. Casali. Rare tumors are classified as such if considered individually, but represent collectively one-fourth of all cancer cases. "People with rare diseases have the same right to receive proper treatment as all other patients", he added, "which is why it is important that a pan-European organization like ESMO is active in this field."


Contact: Vanessa Pavinato
European Society for Medical Oncology

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
3. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
4. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
5. Poll Shows Voters Want Long Term Care Included in Presidential Candidates Healthcare Proposals, Released at 2007 National Long Term Care Symposium
6. Cosmetic Bootcamp Solidifies Lead as Investor Symposium for Aesthetic Medicine
7. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
8. AMIAs 31st Annual Symposium Opens in Chicago, IL
9. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
10. Aesthetic Extender Symposium, LLC Announces its Inaugural Event
11. New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology: